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Abstract
Purpose: To report the chorioretinal coloboma, and its association with increased risk of retinal 
detachment (RD) and choroidal neovascularization (CNV).
Methods: This retrospective case series included eyes with chorioretinal coloboma diagnosed between 1995 
and 2014 with a focus on RD and CNV as related complications. Cases of CNV were managed with laser 
photocoagulation or intravitreal injection of bevacizumab. For eyes with CNV, therapeutic success was 
defined as resolution of the subretinal hemorrhage on fundus examination and resolution of the subretinal 
and intraretinal fluid on optical coherence tomography (OCT). For eyes with RD, anatomic success following 
surgical intervention was defined as attachment of the retina at the last follow‑up visit.
Results: Fifty‑one eyes of 31 patients with chorioretinal coloboma were identified for review. Bilateral 
chorioretinal coloboma was present in 64.5% of subjects. RD developed in 15 eyes (29.4%). Among 15 eyes 
with RD, 4 eyes (27%) had retinal breaks identified within the coloboma, 5 eyes (33%) had retinal breaks 
outside the coloboma, 2 eyes (13%) showed retinal breaks both inside and outside the coloboma, and in 
4 eyes (27%) the causative retinal break was not localized. The overall rate of anatomic success after RD 
repair was 85.7%. CNV developed in 7 eyes (13.7%) and was located along the margin of the coloboma in 
all cases. CNV was bilateral in 2 of the 5 affected individuals (40%).
Conclusion: RD and CNV were present in a high percentage of eyes with chorioretinal coloboma in these 
series. The frequent finding of retinal breaks outside the coloboma bed suggests that vitreoretinal interface 
abnormalities may play a role in development of RD in these eyes.
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INTRODUCTION
Chorioretinal coloboma is an uncommon congenital 
anomaly of the posterior segment occurring as a 
consequence of incomplete closure of the embryonic 
fissure during fetal development. Anatomical 
alterations in colobomatous eyes include atrophic retina, 
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staphylomatous sclera, and absence of retinal pigment 
epithelium (RPE), Bruch’s membrane, choriocapillaris, 
and choroid. RPE is thickened at the edge of the 
colobomas.[1]
Patients with posterior segment colobomas are at risk 
for retinal detachment (RD) occurring as a consequence 
of retinal breaks located: (a) Outside the area of the 
coloboma, (b) inside the anomalous retinal tissue within 
the coloboma, or (c) both.[2] Colobomatous eyes are also 
at greater risk for choroidal neovascularization (CNV) 
caused by breaks in Bruch’s membrane at the margin 
of the colobomas.[3] Herein, we retrospectively review 
a series of eyes with chorioretinal coloboma seen at our 
practice between 1995 and 2014, with a focus on the 
related complications of RD and CNV.
METHODS
This is an Institutional Review Board approved 
retrospective chart review of 31 patients (51 eyes) 
with a diagnosis of chorioretinal coloboma seen at 
Associated Retinal Consultants in Royal Oak, Michigan, 
USA between 1995 and 2014. All procedures were 
in line with the tenets of the Declaration of Helsinki. 
Patient demographics, clinical ophthalmic features, 
best corrected Snellen visual acuities (BCVA), and 
type of interventions were recorded. For eyes with 
RD, anatomic success following surgical intervention 
was defined as attachment of the retina at the last 
follow‑up visit. For eyes with CNV, therapeutic 
success was defined as resolution of the subretinal 
hemorrhage on fundus examination and resolution of 
the subretinal and intraretinal fluid on optical coherence 
tomography (OCT).
RESULTS
Thirty‑one patients with chorioretinal coloboma were 
identified. Since chorioretinal coloboma was present 
bilaterally in 20 (64.5%) patients, 51 eyes were included 
in this series. The male:female ratio was 14:17. Among 
patients with unilateral chorioretinal coloboma, 8 and 
3 were affected in the right and left eyes, respectively. 
The chorioretinal colobomas were mostly located in 
the typical inferonasal location, though macular and 
optic nerve involvement was noted in 14/51 (27.4%) 
and 35/51 (68.7%) of eyes, respectively. An isolated 
peripapillary chorioretinal defect was present in 
15/51 (29.4%) eyes. The mean and median duration of 
follow‑ up for the total pool of patients was 43 and 11 
months, respectively.
An isolated retinal tear without RD was present in 
2/51 (4%) of eyes in this series. Both tears were located in 
periphery, outside of the bed of the coloboma. One retinal 
tear was treated with laser, and for the treatment of the 
other cryotherapy was performed. Retina was attached 
in both eyes at the last follow‑up evaluation. BCVA of 
the eye treated with laser was 20/400 both pre‑ and 
post‑retinopexy. The eye treated with cryotherapy 
had final BCVA of 20/30, with no pretreatment BCVA 
recorded due to the patient’s young age.
RD was present in 29.4% (15/51) of eyes at the initial 
referral visit. Mean age at presentation was 11 years 
(median 5 years; range, 6 weeks to 69 years). In eyes 
with RD, 27% (4/15) had retinal breaks identified within 
the coloboma, 33% (5/15) had retinal breaks outside the 
coloboma, 13% (2/15) had retinal breaks both inside and 
outside the coloboma, and in 27% (4/15) the causative 
retinal break was not localized [Figure 1]. One eye 
presented with a concurrent choroidal detachment. Of 
15 eyes with RD, 6 eyes (40%) subsequently developed 
proliferative vitreoretinopathy (PVR). The information 
pertaining to each eye with RD is summarized in 
Table 1.
Of 15 eyes with RD, surgical repair was attempted in 
14 eyes (93.3%). One eye was already phthisical at the 
time of presentation and did not undergo RD surgery. 
The total number of retinal reattachment procedures 
performed in this group was 28, with a mean of 2 
interventions per eye. The initial surgical approach 
was generally pars plana vitrectomy with intraocular 
tamponade (93%, 13/14 eyes). Silicone oil was used as the 
intraocular tamponade in primary surgeries in 8 out of 13 
eyes (61.5%). Finally, silicone oil was used in 77% (10/13) 
of eyes. The oil was ultimately removed in 30% (3/10) of 
eyes in which it was employed. One eye with silicone oil 
tamponade was complicated by migration of the oil into 
the anterior chamber with resultant glaucoma, zonular 
dehiscence, and band keratopathy (10%). Endolaser 
Figure 1. Location of retinal breaks in eyes with colobomatous 
retinal detachments. Four RDs (26.7%) had retinal breaks that 
originated within the bed of the coloboma. Five RDs (33.3%) 
had retinal breaks outside of the coloboma. Two RDs (13.3%) 
had retinal breaks identified both inside and outside the 
coloboma. The origin of the detachment was uncertain in 4 
RDs (26.7%).
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photocoagulation was performed around the margin 
of the coloboma in 50% (7/14) of eyes with retinal 
detachment.
Anatomic success in this series was defined as the 
retina remaining attached at the last follow‑up visit, 
irrespective of the number of surgeries. The overall 
rate of anatomic success achieved after RD repair was 
86% (12/14 eyes). Out of the 13 eyes that underwent 
vitrectomy, 11 (85%) had reattached retinas at the last 
follow‑up visit. Of the 10 eyes that received silicone oil 
tamponade, 8 (80%) maintained anatomic success up to 
the last follow‑up visit. Mean and median follow‑ up 
length for all surgeries was 40.8 and 11 months, 
respectively.
Final BCVA data were available for 10 out of 14 eyes 
with RD, as age was a limiting factor for measuring 
the BCVA in some children. Sixty percent (6/10) of 
eyes had the final vision of hand motion (HM) or light 
perception (LP). One eye had the final BCVA of 20/80 
after scleral buckling. Another eye presenting with a 
macula‑sparing giant retinal tear away from the margin 
of the coloboma showed the final BCVA of 20/25 after 
scleral buckling and pars plana vitrectomy (PPV) with 
gas tamponade.
Fourteen percent (7/51) of eyes with chorioretinal 
coloboma developed CNV. Two of the five (40%) 
affected individuals had bilateral CNV. Mean age 
at presentation was 21.8 years (range, 10.5 months 
to 67 years). The CNV was located at the margin 
of the coloboma and within the macula in all eyes. 
Management of CNV in this series consisted of either 
laser photocoagulation (5/7, 71.4% of eyes), intravitreal 
bevacizumab (1/7, 14.3% of eyes), or observation (1/7, 
14.3% of eyes). The eye treated pharmacologically 
received two monthly intravitreal bevacizumab (IVB) 
injections over a 10‑week period. Only one eye was 
observed. All eyes showed resolution of subretinal 
hemorrhage and intraretinal and subretinal fluid at the 
last follow‑up visit. Final BCVA was available for 3 out 
of 5 patients. The information pertaining to each case 
of CNV, along with comparison to other cases reported 
in the literature, is summarized in Table 2. Mean and 
median follow up lengths for all CNV cases were 85.3 
and 12 months, respectively.
The most common associated ocular feature was 
iris coloboma in 33% (16/49) of eyes. Other associated 
findings were CHARGE syndrome (coloboma, heart 
defects, atresia of the choanae, retardation of growth, 
genitourinary and ear abnormalities) in 7% (2/31) of 
patients, and MPPC syndrome (microcornea, posterior 
megalolenticonus, persistent fetal vasculature syndrome, 
coloboma) in 7% (2/31) of patients. Oculo‑digital‑dental 
syndrome (1/31 patients, 3%) and chromosome 22q11 
gene deletion (1/31 patients, 3%) were noted as well.
DISCUSSION
Retinal Detachment in Eyes with Chorioretinal 
Coloboma
The incidence of RD in our series (31%) was within 
the range (2.4–42%) reported by prior studies.[1,4‑6] The 
high rate of RD in our series is likely a consequence of 
sequestration bias, as our center is a tertiary referral 
center for vitreoretinal diseases.
RD occurring in the setting of chorioretinal coloboma 
is particularly challenging to repair.[1] In our study, 43% 
of eyes with RDs required multiple procedures to achieve 
anatomic success. Of the eyes that underwent surgery, 
86% showed successful reattachment of the retina at the 
last follow‑up visit (mean follow‑up period, 3.4 ± 3.0 
years). Other reports in the literature cite success rates 
that range from 35‑100% at last follow up visit.[5,7‑18] Most 
notably, Gopal et al reported a 75% reattachment rate in 
the largest review of surgical management of RD in 85 
colobomatous eyes.[9]
Previous authors have postulated that the area of 
neurosensory retina within the coloboma (referred to 
as the intercalary membrane) is the most common area 
for breaks and detachments.[1,9] In the current study, 
only 40% of RDs had tears within or at the margin of the 
coloboma, which falls on the lower end of previously 
reported rates of 38–100%.[7‑10,12,13,19] Two colobomatous 
eyes in our study presented with a retinal tear without 
detachment, and both retinal breaks were located outside 
the colobomas. This may indicate the possibility of an 
abnormal vitreoretinal interface in colobomatous eyes 
that is not necessarily limited to the area of the coloboma 
and its margins. It also underscores the importance of 
conducting regular dilated funduscopic examinations 
focusing on the peripheral retina, in addition to the 
coloboma itself, for the identification of retinal tears.
Eyes with retinal breaks and detachment identified 
outside the margin of the coloboma may be managed 
with conventional scleral buckling techniques, though 
anatomical success rates are not encouraging, ranging 
from 35 to 57%.[8,10] Breaks that occur within or along the 
margin of the coloboma present a more complex surgical 
challenge.[7,13,19] PPV, intraocular tamponade with either 
silicone oil or gas, and endophotocoagulation over the 
margin of the coloboma are common techniques for 
managing such detachments.
PPV offers the ability to identify and treat breaks in 
the intercalary membrane by endophotocoagulation, 
cryotherapy, or cyanoacrylate glue.[12,17] In a review of 
surgical management of RD related to colobomas, Gopal 
and colleagues performed PPV and intraocular tamponade 
with either silicone oil (94%) or perfluoropropane (6%) 
in 85 eyes. They found that 81.2% of the retinas were 
still attached with a mean follow up of 13.4 months, and 
69.4% of patients had final VA equal to or better than 
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Table 2. Demographics, treatment details, and visual outcomes of patients who developed choroidal neovascular membranes
Author Case Age 
(years)
Extent of 
coloboma 
involvement
CNVM along 
edge of 
coloboma
Treatment Regression 
of CNVM
Initial 
VA
Final 
VA
Follow-up
Hussain 
et al
1 15 ONH, mac, 
iris OD
Yes laser OD Yes 20/200 
OD
20/320 
OD
16.25 years
2 0.88 ONH, mac 
OU
Yes laser OU Yes F+F 
OU
20/150 
OD, 
HM 
OS
17.25 years
3 1 ONH, mac 
OU
Yes laser OU Yes F+F 
OU
F+F 
OU
10 months
4 67 ONH, mac 
OU
Yes IVB OS x2 Yes CF OS 20/200 
OS 
2.4 months
5 25 ONH, mac 
OU
Yes observation Yes HM HM 1 year
Goodwin 
et al[3]
6 1.5 Yes IVR 
x2+laser
Yes NR NR 12 years
Naithani 
et al[31]
7 5 ONH, mac 
OD
Yes IVB x2 Yes 3/60 
OD
6/12 2 years
8 8 ONH, mac 
OU
Yes IVB Yes 6/18 
OS
6/12 2 years
Rajendran 
et al[30]
9 36 ONH, mac 
OD
Yes IVB Yes 6/36 
OD
6/9 1 year
Bhende 
et al[32]
10 56 ONH, mac 
OU, iris OD
Yes PDT+IVB Yes 20/63 
N6
20/32 
N6
39 months
11 21 ONH, mac, 
iris OU
Yes PDT+IVB Yes 20/120 
N6
20/86 
N6 
11 months
12 35 ONH, mac 
OS
Yes PDT Yes 20/32 
N8
20/20 
N6
5 months
Von Eicken 
et al[33]
13 5.5 ONH, mac Yes PDT Yes 0.04 0.2 5.5 years
Maberley 
et al[24]
14 57 ONH, mac, 
iris OU
Yes laser Yes 20/50 20/50 NR
Brodsky 
et al[25]
15 1 ONH, mac, 
iris OD
Yes laser NR NR 3 months
Steahly 
et al[26]
16 29 ONH, mac 
OU
Yes laser x2 Yes 20/200 20/30 33 months
Guirgis 
et al[27]
17 1.75 ONH, mac 
OD
Yes laser Yes N/A 20/100 63 months
Dailey 
et al[28]
18 48 ONH, mac 
OD
Yes laser Yes 20/50 
OD
20/40 >1 year
Spitzer 
et al[29]
19 28 ONH, mac 
OU
Yes laser x2 Yes 20/400 
OS
20/160 12 years
Leff et al[34] 20 65 ONH and 
mac OU, iris 
OD
Yes observation NR 20/400 
OD
NR NR
21 70 ONH, mac, 
iris OU
Yes observation NR 20/70 
OD
NR NR
Rouland 
et al[35]
22 26 ONH, mac, 
iris OU
Yes observation CF 6 
feet
NR NR
Gupta 
et al[23]
23 20 ONH, ma, iris 
colobomas 
OU
Yes observation NR NR NR NR
Takenaka 
et al[22]
24 44 ONH, mac 
OU
Yes observation Yes NR 0.2 6 years
Data from other papers is presented for comparison. OD, right eye; OS, left eye; OU, both eyes; VA, visual acuity; ONH, optic nerve 
head; Mac, macula; CNVM, choroidal neovascular membrane; RD, retinal detachment; IVB, intravitreal bevacizumab; IVR, intravitreal 
ranibizumab; PDT, photodynamic therapy; F+F, fix and follow; CF, count fingers; HM, hand motion; NR, not reported
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10/200.[9] We believe that no single technique could be 
applied universally to all cases of chorioretinal coloboma 
with RD. The surgical planning should be individualized 
with careful preoperative assessment of the RD.
Colobomatous RD is difficult to repair successfully, 
and visual prognosis is guarded, particularly in cases 
involving the macula.[8] In our series, the visual outcomes 
of RD repair were similarly unfavorable, as 6 out of 10 
eyes (60%) had BCVA of HM or worse. The four eyes 
with final BCVA better than HM developed retinal 
breaks outside the coloboma, and the detachments did 
not involve the macula. Only four eyes had preoperative 
BCVA measurements, and the postoperative BCVA for 
each eye was either stable or slightly worse at the last 
follow‑up. The amblyogenic effects of RD at an early 
stage of visual pathway development must be considered 
when discussing the limited final visual acuities in these 
patients, some of them being very young.
Given the guarded visual prognosis and frequent 
need for multiple surgeries, some may question the 
utility of operating on eyes with colobomatous RDs. 
However, a previous review of pediatric RDs found that 
38% of eyes that underwent surgical repair had equal or 
better BCVA compared to their fellow eye at the final 
follow‑up.[20] Furthermore, 89% of those patients had 
bilateral involvement of ocular abnormalities that could 
potentially limit vision. In our series, 65% of patients 
had bilateral chorioretinal colobomas, placing them at 
heightened risk of potential vision loss from RD and 
CNV in both eyes. Within the context of potential future 
vision loss in the currently uninvolved eye, the decision 
to operate on such complicated eyes with generally 
guarded prognoses remains appropriate.
The difficult management of colobomatous RDs and 
the heightened risk of RD in the setting of colobomas 
compel us to consider the need for prophylactic laser 
in all patients with chorioretinal colobomas. A recent 
review of chorioretinal colobomas in a pediatric 
population found a prevalence of 2.9% for RD in eyes 
that received prophylactic laser around the margin of 
the coloboma, as compared to 24.9% in eyes that did 
not receive laser.[21] In our series, only 40% (6/15) of RDs 
had tears within or at the margin of the coloboma, and 
the two colobomatous eyes in our study that presented 
with a retinal tear without detachment had retinal breaks 
located outside the coloboma. Given our findings, if 
one were to decide to perform prophylactic laser in 
eyes with chorioretinal colobomas, a greater benefit 
may be provided by lasering both around the margin 
of the coloboma and around the vitreous base (360°). If 
the margin of the coloboma extends significantly into 
the macula or abuts the fovea, the risk for significant 
visual impairment caused by laser may outweigh the 
benefit of prophylaxis for RD. This issue must also be 
carefully considered intraoperatively during repair of a 
colobomatous RD.
Choroidal Neovascularization in Eyes with 
Chorioretinal Colobomas
The literature regarding coloboma associated CNV 
is currently limited to case reports and small case 
series. To the authors’ knowledge, the current series 
of 7 eyes (5 patients) with chorioretinal colobomas and 
associated CNV represent the largest series reported to 
date.
The untreated natural history of coloboma associated 
CNV ranges from spontaneous resolution [22] to 
progressive worsening of visual acuity.[23] The primary 
modalities available for treatment of CNV are intravitreal 
injections of anti‑vascular endothelial growth factor (anti‑
VEGF), focal laser photocoagulation, and photodynamic 
therapy (PDT). Laser photocoagulation is the most 
frequently used method reported in the literature and 
has consistently resulted in regression of the CNV and 
improvement of visual acuity in these cases.[24‑29] It is 
generally avoided in cases of juxtafoveal or subfoveal 
CNV due to the high risk of iatrogenic vision loss.
In this series, CNV generally developed at a young 
age (median age of 15 years). The three children 
treated with laser had a mean age of 5.6 years (range, 
10 months to 15 years). All five eyes treated with 
laser showed regression of CNV at the last follow‑ up 
examination (mean follow‑up period, 11.3 ± 8.8 years). 
Visual acuity data was available for one patient treated 
with laser, and BCVA remained stable at 20/200 two 
months after treatment. Other studies have reported 
improvements in BCVA of 20/200 to 20/30 (33‑month 
follow‑up), 20/50 to 20/40 (>1‑year follow‑up) and 
20/400 to 20/160 (12‑year follow‑up).[26,28,29]
All eyes treated for CNV in our study showed regression 
of subretinal hemorrhage and fluid. Several authors 
have reported the use of anti‑VEGF injections and/or 
PDT in treating coloboma related CNV, summarized in 
Table 2.[3,30‑35] In the current series, intravitreal bevacizumab 
was used to successfully treat coloboma associated CNV 
in a 67‑year‑old patient with subfoveal hemorrhage and 
CNV. She had successful resolution of the hemorrhage 
and improvement in BCVA from CF to 20/200 at 2‑month 
follow‑up. The one patient who did not receive an 
intervention in our study had spontaneous regression of 
CNV after one month, and fluorescein angiography did 
not show evidence of leakage 12 months later.
Limitations of this study include its retrospective 
nature and limited patient population. Sequestration 
bias may skew the percentages toward a higher rate of 
CNV and RD, as patients with complex retinal pathology 
are more likely to be referred to a tertiary care center for 
management. Visual acuity data are limited in this study, 
as many patients were young children in whom visual 
acuity could not be reliably tested in the clinic setting.
In conclusion, chorioretinal colobomas are rare 
congenital anomalies that have potential to result in 
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complications of RD and CNV. In cases of coloboma 
associated RD, often times multiple surgeries are 
necessary to achieve anatomic success. It is possible that 
an abnormality of the vitreoretinal interface may play a 
role in RD, given that a high percentage of retinal breaks 
were not found within the coloboma boundaries in this 
study. Coloboma associated CNV usually arises on the 
border of the colobomas. These cases can be successfully 
managed with laser or anti‑VEGF therapy.
Financial Support and Sponsorship
Nil.
Conflicts of Interest
There are no conflicts of interest.
REFERENCES
1. Jesberg DO, Schepens CL. Retinal detachment associated with 
coloboma of the choroid. Arch Ophthalmol 1961;65:163‑173.
2. Michaels RG, Wilkinson CP, Rice T. Retinal Detachment. St. Louis: 
The C.V. Mosby Company; 1990.
3. Goodwin P, Shields CL, Ramasubramian A, Brown GC, 
Shields JA. Ranibizumab for coloboma‑related choroidal 
neovascular membrane in a child. J AAPOS 2009;13:616‑617.
4. Maumenee IH, Mitchell TN. Colobomatous malformations of the 
eye. Trans Am Ophthalmol Soc 1990;88:123‑132.
5. Daufenbach DR, Ruttum MS, Pulido JS, Keech RV. Chorioretinal 
colobomas in a pediatric population. Ophthalmology 
1998;105:1455‑1458.
6. Patnaik B, Kalsi R. Retinal detachment with coloboma of the 
choroid. Indian J Ophthalmol 1981;29:345‑349.
7. McDonald HR, Lewis H, Brown G, Sipperley JO. Vitreous surgery 
for retinal detachment associated with choroidal coloboma. Arch 
Ophthalmol 1991;109:1399‑1402.
8. Ramezani A, Dehghan MH, Rostami A, Ahmadieh H, Entezari M, 
Soheilian M, et al. Outcomes of retinal detachment surgery in eyes 
with chorioretinal coloboma. J Ophthalmic Vis Res 2010;5:240‑245.
9. Gopal L, Badrinath SS, Sharma T, Parikh SN, Shanmugam MS, 
Bhende PS, et al. Surgical management of retinal detachments 
related to coloboma of the choroid. Ophthalmology 1998;105:804‑809.
10. Wang K, Hilton GF. Retinal detachment associated with coloboma 
of the choroid. Trans Am Ophthalmol Soc 1985;83:49‑62.
11. Fu SJ, Weng NQ. Retinal detachment associated with coloboma 
of choroid. Zhonghua yan ke za zhi 1989;25:15‑17.
12. Hanneken A, de Juan E, Jr, McCuen BW, 2nd. The management 
of retinal detachments associated with choroidal colobomas by 
vitreous surgery. Am J Ophthalmol 1991;111:271‑275.
13. Jalali S, Das T. Selection of surgical technique for retinal 
detachment with coloboma of the choroid. Indian J Ophthalmol 
1994;42:27‑30.
14. Corcostegui B, Guell JL, Garcia‑Arumi J. Surgical treatment 
of retinal detachment in the choroidal colobomas. Retina 
1992;12:237‑241.
15. Teoh SC, Mayer EJ, Haynes RJ, Grey RH, Dick AD, Markham RH. 
Vitreoretinal surgery for retinal detachment in retinochoroidal 
colobomata. Eur J Ophthalmol 2008;18:304‑308.
16. Unlu N, Kocaoglan H, Acar MA, Aslan BS, Duman S. Surgical 
management of retinal detachment with choroidal coloboma. Eur 
J Ophthalmol 2002;12:299‑303.
17. Hotta K, Hirakata A, Hida T. The management of retinal 
detachments associated with choroidal colobomas by 
vitrectomy with cyanoacrylate retinopexy. Jpn J Ophthalmol 
1998;42:323‑326.
18. Pal N, Azad RV, Sharma YR. Long‑term anatomical and visual 
outcome of vitreous surgery for retinal detachment with choroidal 
coloboma. Indian J Ophthalmol 2006;54:85‑88.
19. Gopal L, Kini M, Badrinath SS, Sharma T. Management of 
retinal detachment with choroidal coloboma. Ophthalmology 
1991;98:1622‑1627.
20. Fivgas GD, Capone A, Jr. Pediatric rhegmatogenous retinal 
detachment. Retina 2001;21:101‑106.
21. Uhumwangho OM, Jalali S. Chorioretinal coloboma in a paediatric 
population. Eye 2014;28:728‑733.
22. Takenaka J, Yimane K, Minamoto A, Mishima HK, Hayashida H. 
Subretinal neovascularization associated with retinochoroidal 
coloboma. Eur J Ophthalmol 2005;15:815‑817.
23. Gupta V, Gupta A, Dogra MR. Subretinal neovascularization 
associated with retinochoroidal coloboma. Indian J Ophthalmol 
1997;45:116‑117.
24. Maberley AL, Gottner MJ, Antworth MV. Subretinal 
neovascularization associated with retinochoroidal colobomas. 
Can J Ophthalmol 1989;24:172‑174.
25. Brodsky MC, Ford RE, Bradford JD. Subretinal neovascular 
membrane in an infant with a retinochoroidal coloboma. Arch 
Ophthalmol 1991;109:1650‑1651.
26. Steahly LP. Laser treatment of a subretinal neovascular membrane 
associated with retinochoroidal coloboma. Retina 1986;6:154‑156.
27. Guirgis MF, Lueder GT. Choroidal neovascular membrane 
associated with optic nerve coloboma in a patient with CHARGE 
association. Am J Ophthalmol 2003;135:919‑920.
28. Dailey JR, Cantore WA, Gardner TW. Peripapillary choroidal 
neovascular membrane associated with an optic nerve coloboma. 
Arch Ophthalmol 1993;111:441‑442.
29. Spitzer M, Grisanti S, Bartz‑Schmidt KU, Gerlisken F. Choroidal 
neovascularization in retinochoroidal coloboma: Thermal laser 
treatment achieves long‑term stabilization of visual acuity. Eye 
2006; 20:969‑972.
30. Rajendran A, Gupta SR, Brahadeesh S, Ramasamy K. Intravitreal 
bevacizumab for choroidal neovascularization associated with a 
retinochoroidal coloboma. Eye 2010; 24:933‑934.
31. Naithani P, Vashisht N, Mandal S, Sankaran P, Garg S. 
Intravitreal bevacizumab in choroidal neovascularization 
associated with congenital choroidal and optic nerve coloboma 
in children: Long‑term improvement in visual acuity. J AAPOS 
2010;14:288‑290.
32. Bhende M, Suganeswari G, Gopal L, Bhende PS, Gopal L, 
Rao C. Choroidal neovascularization associated with coloboma 
of the choroid: A series of three cases. Indian J Ophthalmol 
2011;59:148‑151.
33. von Eicken J, Hoh H, Rehfeldt K. Photodynamic therapy for 
choroidal neovascularisation due to choroidal coloboma in a 
5 1/2‑year‑old child. Klin Monbl Augenheilkd 2007;224:140‑145.
34. Lef f  SR ,  Br i t ton  WA,  J r . ,  Brown GC,  Luc ier  AC, 
Brown JF. Retinochoroidal coloboma associated with subretinal 
neovascularization. Retina 1985;5:154‑156.
35. Rouland JF, Constantinides G. Retinochoroidal coloboma and 
subretinal neovascularization. Ann Ophthalmol 1991;23:61‑62.
